Carvalho, JS

Chaoui, R

Copel, JS

Cuneo, B

Hecher, K

Herrera, M

Lee, W

Palladini, D

Tutschek, B

Yagel, S

Crossref

OC11.04: Fetal surveillance of anti-Ro/anti-La affected pregnancies: is there a consensus? Results of an international survey

St George's Online Research Archive

28/06/2018, 23:28ScholarOne Abstracts - Abstract proof popupPage 1 of 2https://isuog2018.abstractcentral.com/submission?PARAMS=xi…pNRqeKki3romaKMELABdv1p3deBpta5HuFgFh4NmiDocb9R2DpXb8r6LpzView AbstractSUBMISSION ROLE: General Abstract SubmissionCONTROL ID: 3002582TITLE: Fetal surveillance of anti-Ro/anti-La affected pregnancies: is there a consensus? Results of aninternational surveyAUTHORS (FIRST NAME, LAST NAME): Julene S. Carvalho , Rabih Chaoui , Joshua A. Copel , KurtHecher , Mauricio Herrera , Wesley Lee , Dario Paladini , Boris Tutschek , Simcha Yagel , Bettina CuneoINSTITUTIONS (ALL): 1. Brompton Centre for Fetal Cardiology, Royal Brompton Hospital, London, UnitedKingdom. 2. Molecular & Clinical Sciences Research Institute, St George's University of London, London, UnitedKingdom. 3. Center for Prenatal Diagnosis and Human Genetics, Berlin, Germany. 4. Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, New Haven, CT, United States. 5. Dept of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 6. Fetal Medicine & Surgery Unit, G.Gaslini Hospital, Genoa, Italy. 7. Fetal Medicine and Gynecological Ultrasound, Prenatal Zurich, Zurich, Switzerland. 8. OBGYN, Baylor College of Medicine, Houston, TX, United States. 9. Obstetrics and Gynecology, Hadassah-Hebrew University Medical Centers, Mt. Scopus, Jerusalem, Israel. 10. The Heart Institute, Children's Hospital Colorado, Denver, CO, United States. 11. Maternal Fetal Medicine Department, Maternal Fetal Medicine Unit- Colombia University Clinic - FetalClinic- Sanitas University, Bogota, Bogota, Colombia. ABSTRACT BODY: Objectives: Surveillance of pregnancies affected by maternal anti-Ro/ anti-La auto-antibodies (AB) with regardfetal cardiac monitoring is controversial. The aim of this study was to obtain an overview of current practiceworldwide.Methods: A web-based survey was developed by members of ISUOG Fetal Heart Interest Group. Link to thesurvey was sent via Newsletter to all ISUOG and Fetal Heart Society members and by direct email to UK fetalcardiologists and members of AEPC fetal working group. Additional emails were sent directly to otherworldwide professionals known to manage such pregnancies.Results: There were 92 respondents. About ½ were cardiologists and ½ obstetricians or fetal medicinespecialists. Nearly 40% manage <5 cases/year and only ~10% see >20cases/year. For about half of therespondents, ‘positive’ anti-Ro/La is the only information known in > 90% of cases seen. About one quarterknow AB titers and just over 10% are aware of anti-Ro subtypes for > 90% of cases. With no previouslyaffected child, about half use echo and fetal heart rate monitoring and about one quarter use echo alone. Mostrespondents (~ 2/3) would start monitoring at 16-20weeks. Frequency of monitoring varied, being every 2weeks in ~40%, and weekly in about one quarter of responses. From replies, there was no consensus on howlong to monitor the pregnancy for. If 1  degree atrioventricular (AV) block or myocardial abnormalities werefound, most (50-60%) would increase frequency of scans and ~40% would start steroids. Most use leftventricular inflow-outflow Doppler to measure the AV interval, but there is no consensus on how to define 1degree AV block. With a previously affected child, most would monitor the pregnancy differently but ~20%would not.Conclusions: Although there were some trends, there was no clear consensus on how to monitor thesepregnancies. Evidence-based guidelines are likely to optimize fetal surveillance.Additional detailsCURRENT TOPIC: ObstetricsCURRENT SUB-TOPIC: 02. Fetal heart, CHD and cardiac functionPRESENTATION TYPE: No PreferenceAWARDS:KEYWORDS: Echocardiography, Fetal heart.ISUOG2, 1 3 45 11 8 6 7 9 10stst28/06/2018, 23:28ScholarOne Abstracts - Abstract proof popupPage 2 of 2https://isuog2018.abstractcentral.com/submission?PARAMS=xi…pNRqeKki3romaKMELABdv1p3deBpta5HuFgFh4NmiDocb9R2DpXb8r6Lpz© Clarivate Analytics | © ScholarOne, Inc., 2018. All Rights Reserved.ScholarOne Abstracts and ScholarOne are registered trademarks of ScholarOne, Inc.ScholarOne Abstracts Patents #7,257,767 and #7,263,655.! @ScholarOneNews | " System Requirements | # Privacy Statement | $ Terms of UseProduct version number 4.15.1 (Build 33). Build date Jun 28, 2018 11:52:46. Server c559prhs1asSUPPLEMENTAL DATA: none(No Table Selected)(No Image Selected)

Fetal surveillance of anti-Ro/anti-La affected pregnancies: is there a consensus? Results of an international survey

http://openaccess.sgul.ac.uk/109930/1/Anti-Ro%20survey_Abstract%20proof_Final.pdf

Fetal surveillance of anti-Ro/anti-La affected pregnancies: is there a consensus? Results of an international survey

Abstract

Similar works

Full text

Available Versions

Crossref

St George's Online Research Archive